Injective Price Eyes Reversal Above $50 as MACD Signal Aligns With SEC Filing
Covered by 2 sources · 2 articles
2 outlets - including Coin-turk and Tronweekly - are covering this story. 🚀 Injective flashes bullish MACD crossover with a breakout target above $50. 🟢 $INJ strengthens its US and European regulatory position for real-world assets expansion. 🌍 Analyst optimism grows as Injective eyes major institutional adopt…
All coverage
Injective eyes $50 breakout after bullish MACD signal and US, EU regulatory wins
🚀 Injective flashes bullish MACD crossover with a breakout target above $50. 🟢 $INJ strengthens its US and European regulatory position for real-world assets expansion. 🌍 Analyst optimism grows as Injective eyes major institutional adopt…
Injective Price Eyes Reversal Above $50 as MACD Signal Aligns With SEC Filing
Injective is attracting renewed market attention as a bullish MACD crossover strengthens technical sentiment while new regulatory progress in the US and Europe supports its real-world asset strategy. Traders are now watching whether growing…